CD69 expression on pDCs in hyperacute treated individuals was similar to uninfected controls but levels were significantly lower at 12-months post-infection in participants starting ART in chronic HIV-1 infection when compared to hyperacute treated persons (p=0.008), with partial recovery after ART initiation (Figure 3C). The gene discussed is CD69; the disease is HIV-1 infection.